Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Camcevi 42 mg (leuprolide 6-month depot)
i
Other names:
FP-001 42 mg, FP-001 LMIS
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Foresee Pharma, GeneScience, Intas
Drug class:
GnRH agonist
Related drugs:
‹
leuprolide acetate (14)
triptorelin (9)
goserelin acetate (7)
histrelin acetate (5)
leuprorelin depot (1)
leuprolide acetate for depot suspension (1)
buserelin acetate (0)
leuprolide acetate (14)
triptorelin (9)
goserelin acetate (7)
histrelin acetate (5)
leuprorelin depot (1)
leuprolide acetate for depot suspension (1)
buserelin acetate (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Prostate Cancer
No biomarker
Prostate Cancer
leuprolide 6-month depot
Sensitive: A1 - Approval
leuprolide 6-month depot
Sensitive
:
A1
leuprolide 6-month depot
Sensitive: A1 - Approval
leuprolide 6-month depot
Sensitive
:
A1
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login